Summary
GLP-1 drugs, originally approved for diabetes and weight loss, are being studied for their potential benefits in reducing risks of various health conditions like Alzheimer's and infections. However, due to high costs and limited insurance coverage, their use is mainly off-label, leading to concerns about availability and affordability. Despite their promise, these drugs can cause significant side effects and their benefits may decrease if discontinued.
Key Facts
- GLP-1 drugs are typically used for diabetes and weight loss but might help in other conditions.
- These drugs could potentially lower risks for conditions like Alzheimer’s and infections.
- A recent study showed GLP-1s reduced health risks by 10% to 20%.
- The drugs are expensive, costing over $1,000 per month without insurance.
- Many uses of GLP-1s are off-label, affecting insurance payments.
- Side effects can include gastrointestinal issues, kidney problems, and low blood pressure.
- More than a third of patients stop using GLP-1s within a year, often due to cost or side effects.
- Research is ongoing to fully understand the effects and workings of GLP-1s.
